PAMS
CLVS

Pictet Asset Management (Switzerland)’s Clovis Oncology, Inc. CLVS Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-10,800
Closed -$22K – 1715
2022
Q1 		$22K Hold
10,800
– – ﹤0.01% 1675
2021
Q4 		$29K Hold
10,800
– – ﹤0.01% 1712
2021
Q3 		$48K Buy
+10,800
New +$52K ﹤0.01% 1727

Other funds holding CLVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return

Pictet Asset Management (Switzerland)'s CLVS Position: Q2 2022 in Review

Pictet Asset Management (Switzerland) sold out of Clovis Oncology, Inc. (CLVS) in Q2 2022, closing a stake of 10,800 shares — an estimated $22K sold.

Pictet Asset Management (Switzerland) first reported a position in CLVS in Q3 2021 and held it in 3 quarters. The position peaked at $48K in Q3 2021. 115 funds tracked by Wall St. Rank hold CLVS as of Q2 2022.

  • Pictet Asset Management (Switzerland) reported no remaining Clovis Oncology, Inc. position as of Q2 2022 after selling out during the quarter.
  • Pictet Asset Management (Switzerland) sold 10,800 Clovis Oncology, Inc. shares in Q2 2022, an estimated $22K.
  • Pictet Asset Management (Switzerland) first reported a position in Clovis Oncology, Inc. in Q3 2021 and held it in 3 quarters.
  • Pictet Asset Management (Switzerland)'s Clovis Oncology, Inc. position peaked at $48K in Q3 2021.
  • 115 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q2 2022.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2022, filed 9 Aug 2022.